Zura Bio Ltd

Zura Bio Ltd is a clinical-stage biopharmaceutical company focused on immunology therapeutics that reached public markets through a business combination with JATT Acquisition Corp (Nasdaq: JATT), a healthcare-focused blank-check company that completed its IPO in 2021. The SPAC was sponsored by JATT Ventures. A Form 10-Q filed May 13, 2022 under accession number 0001410578-22-001433 captures the entity during the pre-close phase of its de-SPAC transaction; the combination subsequently closed and the company now trades under the ticker ZURA on Nasdaq. For complete filing histories, deal timelines, and institutional data across thousands of SPAC transactions, sign up for full access on SpacDesk.